{{knowledge objective
|Identifiant=OIC-177-07-B
|Item_parent=Prescription and monitoring of anti-infectives in adults and children (see item 330)
|Item_parent_short=Prescription and monitoring of anti-infectives in adults and children (see item 330)
|Rank=B
|Heading=Know (indications, contraindications, spectrum, side effects and interactions) the main molecules belonging to the oral third-generation cephalosporins.
|Description=Cefpodoxime, cefixime
|Rubric=Definition
|Contributors=Jean-Philippe Lavigne
|Order=7}}

{| class="wikitable"
|'''Antibiotics'''
|'''Indications'''
|'''Contraindications'''
|'''Spectrum'''
|'''Side effects and interactions'''
|-
|'''Oral 3rd<sup> generation</sup> cephalosporins''''

'''(molecules: cefpodoxime, cefixime)''''
|Beware of their significant ecological impact

Acute pyelonephritis (as a relay to an injectable form), acute bacterial sinusitis in adults, group A streptococcal angina, acute bronchial suppurations in subjects at risk, exacerbations of chronic obstructive bronchitis, acute otitis media in children.
|Hypersensitivity to the active substance or to one of the excipients.
|Gram-positive bacteria (streptococci), group 0, 1 and 2 Enterobacteriaceae
|Allergic reactions, abdominal pain, diarrhoea, nausea, vomiting, tinnitus, headache, dizziness, elevation of AST and ALAT.


Interactions: anti-H2 and antacids
|}